The importance of inflammatory mechanisms for the development of Alzheimer's disease (Q33703419)

28 July 2017

1 reference

title

The importance of inflammatory mechanisms for the development of Alzheimer's disease (English)

1 reference

28 July 2017

0 references

Eikelenboom P

1

1 reference

28 July 2017

Veerhuis R

series ordinal

2

1 reference

28 July 2017

publication date

1 June 1999

1 reference

28 July 2017

published in

Experimental Gerontology

1 reference

28 July 2017

volume

34

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

453-461

1 reference

The syntax of immune-neuroendocrine communication

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

The role of complement and activated microglia in the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Human antibodies reactive with beta-amyloid protein in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Acute-phase proteins in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Increased activity of surviving locus ceruleus neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Association of vascular amyloid beta and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

The Dexamethasone Suppression Test in Alzheimer's Disease and Major Depression: Relationship to Dementia Severity, Depression, and CSF Monoamines

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Acute delirium and functional decline in the hospitalized elderly patient

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Normal and abnormal biology of the beta-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Circulating cytokines in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

The immune-neuro-link and the macrophage: postcardiotomy delirium, HIV-associated dementia and psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Primary and secondary alterations of immune reactivity in the elderly: impact of dietary factors and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2899%2900022-4

7 January 2021

10.1016/S0531-5565(99)00022-4

Identifiers

DOI

1 reference

28 July 2017

1 reference